Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COPD
Pharma
GSK revs up launch plans after Nucala's FDA approval in COPD
The thumbs-up makes Nucala the second biologic approved in COPD and the third new therapy cleared for the disease by the FDA in less than a year.
Fraiser Kansteiner
May 22, 2025 3:10pm
AZ looks to grow Airsupra's reach with new asthma data
May 19, 2025 12:15pm
AZ's Breztri set up for label expansion with 2 asthma trial wins
May 2, 2025 11:30am
Sanofi off to a promising start in launch of Dupixent for COPD
Apr 24, 2025 10:52am
Leerink uses broad model to weigh drugs' cost-effectiveness
Feb 18, 2025 8:56am
Verona's new COPD drug Ohtuvayre racked up sales of $42M in 2024
Jan 7, 2025 1:27pm
